Vyome Holdings Inc (HIND) Net Margin

Vyome Holdings Inc. - graphic logo of issuer HIND

Vyome Holdings Inc is attracting leading immunologists for R&D and developing its own dermatological pipeline without external acquisitions. The net profit margin demonstrates effective cost management, with the parameter reaching -2455.60. The issuer's financial success is based on the synergy between antibacterial developments and obesity treatment equipment, including Lap-Band surgeries.

Vyome Therapeutics (HIND) Return on Sales by Net Profit: for the period 08/16/2025 - 11/20/2026

ReShape Lifesciences (HIND) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Summary company analytics:Vyome Holdings Inc
Finished products of Vyome Holdings Inc.

Sales margins determine the fundamental viability of an asset through the share of net profit in total revenue. This metric measures the remaining funds after covering all operating and tax expenses. The dynamics of the business's net margin efficiency allow for the tracking of the real profitability of each unit of income. For Vyome Holdings Inc (HIND), this indicator reflects the monetization of exclusive patents in the field of immunotherapy. High values confirm the commercial value of scientific developments and long-term clinical programs.

Analysis of competing companies

argenx (ARGX) - Net Margin|BNTX - Company Sales Margin|ABVX (Abivax Pharma) - Net Sales Margin|Return on Sales by Net Profit ADMA Bio (ADMA)|Return on Sales by Net Profit PTGX (Protagonist Therapeutics Inc)|Net Sales Margin immunovant.com (IMVT)|Net Margin kiniksa.com KNSA|Grifols SA (GRFS) - Net Margin|Adaptive Biotechnologies Inc. - Net Sales Margin|Net Margin Celldex Therapeutics|AUPH: Net Sales Margin|BCRX - Company Sales Margin|VERA (Vera Corp) - Net Sales Margin|Dianthus Pharma (DNTH) - Company Sales Margin|Net Margin Pharvaris Pharma (PHVS)|Net Sales Margin AbCellera Corp (ABCL)|Net Sales Margin TRML (Tourmaline Bio Inc)|Company Sales Margin precigen.com (PGEN)|PHAR - Net Margin|Net Profit Rate NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Return on Sales by Net Profit|Zenas Corp (ZBIO) - Net Sales Margin|Return on Sales by Net Profit IMNM|GOSS: Net Profit Rate|Net Margin KalVista Pharma (KALV)|SEPN - Net Margin|Net Sales Margin PVLA (pieris.com)|Net Sales Margin Savara Pharma SVRA|RIGL: Return on Sales by Net Profit|ANAB - Net Sales Margin|ATXS: Net Sales Margin|ENGN - Company Sales Margin|Return on Sales by Net Profit RAPT|JBIO (Aerovate Therapeutics Inc) - Company Net Profitability|Net Sales Margin ACRS|Return on Sales by Net Profit kyvernatx.com KYTX|Net Sales Margin TLSA (Tiziana Life Sciences, Ltd.)|Net Sales Margin Cabaletta Bio CABA|VTYX: Return on Sales by Net Profit|Theratechnologies Inc. (THTX) - Return on Sales by Net Profit|AVTX: Net Sales Margin|ELDN - Company Sales Margin|AGEN (Agenus, Inc) - Net Sales Margin|Net Sales Margin Climb Bio, Inc.|Net Margin Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Net Profit Rate|Net Sales Margin ADAG (Adagene Inc)|IMA - Return on Sales by Net Profit|STTK - Net Margin|EQ (equilliumbio.com) - Net Return on Sales|CNTB: Net Sales Margin|Immunic Inc (IMUX) - Net Sales Margin|ATRA (Atara Biotherapeutics Inc) - Net Sales Margin|Net Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Net Profit Rate|Adicet Bio, Inc. - Net Return on Sales|Celularity Inc - Return on Sales by Net Profit|Net Sales Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Net Sales Margin|Kezar Life Sciences, Inc. (KZR) - Return on Sales by Net Profit|SAB Biotherapeutics Inc. (SABS) - Net Margin|Return on Sales by Net Profit Akari Therapeutics plc|Net Margin enlivex.com|q32bio.com (QTTB) - Company Sales Margin|Net Sales Margin GOVX|Edesa Biotech, Inc. - Net Return on Sales|iBio Inc - Return on Sales by Net Profit|Net Sales Margin Carisma Therapeutics CARM|XTLB - Net Margin|BOLT (boltbio.com) - Net Return on Sales|HCWB: Net Sales Margin|Aptevo (APVO) - Net Sales Margin|Net Margin AIM ImmunoTech|Return on Sales by Net Profit Aditxt (ADTX)|Return on Sales by Net Profit GRI (GRI Bio Corporation)|XORTX - Net Return on Sales|Net Margin Revelation Biosciences REVB|INDP: Net Return on Sales|SCNI - Net Margin|CALI (calcimedica.com) - Net Return on Sales|AFMD (Affimed Therapeutics) - Return on Sales by Net Profit|Allakos Therapeutics (ALLK) - Net Sales Margin|HOOK (HOOKIPA) - Net Sales Margin|igmbio.com (IGMS) - Company Sales Margin|Net Sales Margin ITOS|OCEA (Ocean Biomedical) - Net Profit Rate|Net Sales Margin TCBP (TC BioPharm (Holdings) PLC)|THRD - Return on Sales by Net Profit